Your browser doesn't support javascript.
loading
Loss of fundus view as an indication for secondary enucleation in retinoblastoma.
Berry, Jesse L; Kogachi, Kaitlin; Jubran, Rima; Kim, Jonathan W.
Afiliação
  • Berry JL; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
  • Kogachi K; USC Roski Eye Institute, Keck Medical School of the University of Southern California, Los Angeles, California.
  • Jubran R; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
  • Kim JW; USC Roski Eye Institute, Keck Medical School of the University of Southern California, Los Angeles, California.
Pediatr Blood Cancer ; 65(4)2018 04.
Article em En | MEDLINE | ID: mdl-29218818
ABSTRACT
In this retrospective study, we evaluated loss of fundus view as an indication for secondary enucleation and associated histopathologic findings. Of 64 secondarily enucleated eyes, 24 were enucleated for loss of fundus view. Average time from loss of fundus view to enucleation was 4.7 months. Of these eyes, 22 had viable tumor cells on histopathology, but none had high-risk features. Loss of fundus view was a common indication for secondary enucleation after chemoreduction. Given the high prevalence of viable histopathologic tumor cells, enucleation for loss of fundus view should not be significantly delayed to decrease risk of high-risk tumor progression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinoblastoma / Enucleação Ocular / Neoplasias da Retina / Fundo de Olho Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Retinoblastoma / Enucleação Ocular / Neoplasias da Retina / Fundo de Olho Idioma: En Ano de publicação: 2018 Tipo de documento: Article